Polymorphisms in nucleotide excision repair genes and endometrial cancer risk

Cancer Epidemiology Biomarkers and Prevention

Volumn 20, Issue 9, 2011, Pages 1873-1882

  Doherty, Jennifer A ^a   Weiss, Noel S ^a   Fish, Sherianne ^a   Fan, Wenhong ^a   Loomis, Melissa M ^a   Sakoda, Lori C ^a   Rossing, Mary Anne ^a   Zhao, Lue Ping ^a   Chen, Chu ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 3; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 4; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 5; NUCLEIC ACID BINDING PROTEIN; UNCLASSIFIED DRUG; XERODERMA PIGMENTOSUM GROUP A PROTEIN; XERODERMA PIGMENTOSUM GROUP C PROTEIN; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

ADULT; AGED; ARTICLE; BODY MASS; CANCER PATIENT; CANCER RISK; CIGARETTE SMOKING; COMPARATIVE STUDY; CONTROLLED STUDY; DNA ADDUCT; ENDOMETRIUM CANCER; EXCISION REPAIR; FEMALE; FOLLOW UP; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; CASE-CONTROL STUDIES; DNA HELICASES; DNA LIGASES; DNA REPAIR; DNA-BINDING PROTEINS; ENDOMETRIAL NEOPLASMS; ENDONUCLEASES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; NUCLEAR PROTEINS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; TRANSCRIPTION FACTORS; XERODERMA PIGMENTOSUM GROUP A PROTEIN; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

EID: 80052544714     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-11-0119     Document Type: Article

References (29)

1. Key T.J., Pike M.C. The dose-effect relationship between 'unopposed'oestrogens and endometrial mitotic rate: Its central role in explaining and predicting endometrial cancer risk. Br J Cancer 1988;57:205-212 (Pubitemid 18085407)
2. Siiteri P.K. Steroid hormones and endometrial cancer. Cancer Res 1978;38:4360-4366 (Pubitemid 9054232)
3. Zhu B.T., Conney A.H. Functional role of estrogen metabolism in target cells: Review and perspectives. Carcinogenesis 1998;19:1-27. (Pubitemid 28376821)
4. Roy D., Liehr J.G. Estrogen, DNA damage and mutations. Mut Res 1999;424:107-115 (Pubitemid 29101612)
5. Cavalieri E., Frenkel K., Liehr J.G., Rogan E., Roy D. Estrogens as endogenous genotoxic agents-DNA adducts and mutations. J Natl Cancer Inst Monogr 2000;75-93.
6. Yager J.D., Liehr J.G. Molecular mechanisms of estrogen carcinogenesis. Annu Rev Pharmacol Toxicol 1996;36:203-232 (Pubitemid 26168699)
7. Wogan G.N., Hecht S.S., Felton J.S., Conney A.H., Loeb L.A. Environmental and chemical carcinogenesis. Semin Cancer Biol 2004;14:473-486 (Pubitemid 39360995)
8. Friedberg E.C. How nucleotide excision repair protects against cancer. Nat Rev Cancer 2001;1:22-33. (Pubitemid 33741878)
9. Volker M., Mone M.J., Karmakar P., Van Hoffen A., Schul W., Vermeulen W., et al. Sequential assembly of the nucleotide excision repair factors in vivo. Mol Cell 2001;8:213-224 (Pubitemid 32772919)
10. Weiss J.M., Weiss N.S., Ulrich C.M., Doherty J.A., Voigt L.F., Chen C. Interindividual variation in nucleotide excision repair genes and risk of endometrial cancer. Cancer Epidemiol Biomarkers Prev 2005;14:2524-2530 (Pubitemid 41752710)
11. Doherty J.A., Weiss N.S., Freeman R.J., Dightman D.A., Thornton P.J., Houck J.R., et al. Genetic factors in catechol estrogen metabolism in relation to the risk of endometrial cancer. Cancer Epidemiol Biomarkers Prev 2005;14:357-366 (Pubitemid 40270097)
12. Hankey B.F., Ries L.A., Edwards B.K. The surveillance, epidemiology, and end results program: A national resource. Cancer Epidemiol Biomarkers Prev 1999;8:1117-1121 (Pubitemid 30004912)
13. Waksberg J. Random digit dialing sampling for case-control studies. In: Gail MH, Benichou J, editors. Encyclopedia of epidemiologic methods. New York: John Wiley & Sons; 2000. p. 749-753
14. Marchbanks P.A., McDonald J.A., Wilson H.G., Burnett N.M., Daling J.R., Bernstein L., et al. The NICHD Women's Contraceptive and Reproductive Experiences Study: Methods and operational results. Ann Epidemiol 2002;12:213-221 (Pubitemid 34414934)
15. Bodelon C., Doherty J.A., Chen C., Rossing M.A., Weiss N.S. Use of nonsteroidal antiinflammatory drugs and risk of endometrial cancer. Am J Epidemiol 2009;170:1512-1517
16. Rossing M.A., Cushing-Haugen K.L., Wicklund K.G., Doherty J.A., Weiss N.S. Menopausal hormone therapy and risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 2007;16:2548-2556 (Pubitemid 351196308)
17. NIEHS SNPs. NIEHS Environmental Genome Project, University of Washington. 2001. Available from: http://egp.gs.washington.edu/welcome.html.
18. Plink (v1.07). Center for Human Genetic Research, Massachusetts General Hospital, and Broad Institute. 2009. Available from: http://pngu.mgh.harvard. edu/purcell/plink/.
19. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A., Bender D., et al. PLINK: A tool set for whole-genome association and populationbased linkage analyses. Am J Hum Genet 2007;81:559-575 (Pubitemid 47330214)
20. Li S.S., Khalid N., Carlson C., Zhao L.P. Estimating haplotype frequencies and standard errors for multiple single nucleotide polymorphisms. Biostatistics 2003;4:513-522
21. Zhao L.P., Li S., Khalid N. A method for the assessment of disease associations with single nucleotide polymorphism haplotypes andenvironmental variables in case-control studies. Am J Hum Genet 2003;72:1231-1250 (Pubitemid 36530010)
22. fhcrc.org. Creative Development Services. 2011. Available from: http://cdsweb01.fhcrc.org/HPlus/.
23. Wacholder S., Chanock S., Garcia-Closas M., El Ghormli L., Rothman N. Assessing the probability that a positive report is false: An approach for molecular epidemiology studies. J Natl Cancer Inst 2004;96:434-442 (Pubitemid 38443646)
24. Yuan H-Y, Chiou J-J, Tsang W-H, Liu C-H, Liu C-K, Lin Y-J, et al. FASTSNP: An always up-to-date and extendable service for SNP function analysis and prioritization. Nucleic Acids Res 2006;34:W635-41. Available from: http://fastsnp.ibms.sinica.edu.tw.
25. Jo H., Kang S., Kim S.I., Kim J.W., Park N.H., Song Y.S., et al. The C19007T polymorphism of ERCC1 and its correlation with the risk of epithelial ovarian and endometrial cancer in Korean women. A case control study. Gynecol Obstet Invest 2007;64:84-88 (Pubitemid 47294465)
26. Goode E.L., Ulrich C.M., Potter J.D. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 2002;11:1513-1530 (Pubitemid 36020002)
27. Neumann A.S., Sturgis E.M., Wei Q. Nucleotide excision repair as a marker for susceptibility to tobacco-related cancers: A review of molecular epidemiological studies. Mol Carcinog 2005;42:65-92.
28. Vineis P., Manuguerra M., Kavvoura F.K., Guarrera S., Allione A., Rosa F., et al. A field synopsis on low-penetrance variants in DNA repair genes and cancer susceptibility. J Natl Cancer Inst 2009;101:24-36.
29. Spurdle A.B., Thompson D.J., Ahmed S., Ferguson K., Healey C.S., O'Mara T., et al. Genome-wide association study identifies a common variant associated with risk of endometrial cancer. Nat Genet 2011;43:451-454